Staff Software Engineer at Asimov

Boston, Massachusetts, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

BiotechnologyIndustries

Requirements

10+ years of experience in software development
Technical expertise in Python 3, Strawberry, SQLAlchemy, GraphQL, Elasticsearch, Docker
Sense of urgency and desire to work on challenging technical projects
Ability to navigate the ambiguity of building first-of-its-kind systems
Multiple years of experience building and scaling systems to production-level workloads
Sound technical judgment considering quality, performance, and product stage
Passion for joining a startup where autonomy, passion to learn, and excitement to engineer biology take precedence over process and ego
Experience developing computer-aided design software and/or scientific software applications (desired, though not required)

Responsibilities

Design, build, and maintain software tools used by bioengineers to advance the design and manufacture of biologics and gene therapies
Directly shape the software architecture and be involved in the long-term product direction
Work with a modern backend stack (Python 3, Strawberry, SQLAlchemy)
Develop data models and schemas for the complex domain of biology
Be part of an on-call rotation to support the software you’ve helped develop
Interface directly with members of the synthetic biology team to identify and prioritize potential improvements to software systems
Contribute to Asimov’s technology platform, direction, and culture

Skills

Python

Strawberry

SQLAlchemy

GraphQL

Elasticsearch

Docker

Asimov

Synthetic biology solutions for biopharmaceuticals

About Asimov

Asimov operates in the synthetic biology field, providing a combination of cells, genes, and software to assist in advanced genetic design. Their products include cloud-based software that allows clients in the biopharmaceutical industry to design, simulate, and optimize genetic systems. Additionally, they offer engineered GMP host cells that are used for therapeutic applications. Asimov distinguishes itself from competitors by guaranteeing high titer cell lines for monoclonal antibodies with a promise of '4 g/L or it's free,' which reduces risk for their clients. The company's goal is to enable biopharma companies to produce high-quality protein therapeutics and scalable viral vectors efficiently, supported by their in-house expertise in synthetic biology and process development.

Boston, MassachusettsHeadquarters

2017Year Founded

$199.1MTotal Funding

SERIES_BCompany Stage

AI & Machine Learning, BiotechnologyIndustries

51-200Employees

Risks

Competition from LatchBio's code-free biocomputing infrastructure challenges Asimov's software offerings.

Integration of The Foundry may lead to potential cultural clashes and operational disruptions.

Rapid data generation in synthetic biology may strain Asimov's data processing capabilities.

Differentiation

Asimov offers a '4 g/L or it's free' promise for monoclonal antibodies.

The LV Edge Producer System eliminates GMP plasmid costs and reduces process complexity.

Asimov integrates synthetic biology, computer-aided design, and machine learning for genetic design.

Upsides

Stable cell line development reduces costs and increases scalability in lentiviral production.

Acquisition of The Foundry enhances Asimov's expertise in genetic design and engineering.

Growing biotech investments indicate a robust market for Asimov's engineered cell lines.

Land your dream remote job 3x faster with AI

Try Jobo Free